Slingsby Brian Taylor — SEC insider filings

SEC reporting owner CIK 1963901. 11 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2023-02-13 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mineralys Therapeutics, Inc. (MLYS)Director112 legs · 509,259 sh · $7,499,9963 legs · 1,654,320 sh · $53,532,80318

Insider filings — Slingsby Brian Taylor

FiledFormIssuerReported transactionsSource
2026-09-244Mineralys Therapeutics, Inc. (MLYS)Sale (S): 104,320 @ $28.81EDGAR
2026-02-204Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 6,200 @ $0 · Other (J): 6,200 @ $0 · Other (J): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0 · Other (J): 8,300 (derivative) @ $0 · Other (J): 8,300 (derivative) @ $0EDGAR
2025-11-214Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Sale (S): 1,000,000 @ $43.35EDGAR
2025-04-254Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Purchase (P): 259,259 @ $13.50EDGAR
2025-02-244Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Grant/award (A): 32,900 (derivative) @ $0 · Other (J): 32,900 (derivative) @ $0 · Other (J): 32,900 (derivative) @ $0EDGAR
2025-01-074Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Other (J): 22,000 (derivative) @ $0 · Other (J): 22,000 (derivative) @ $0EDGAR
2024-07-264Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Sale (S): 550,000 @ $13.05EDGAR
2024-05-234Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Grant/award (A): 22,000 (derivative) @ $0EDGAR
2023-07-144Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Other (J): 44,000 (derivative) @ $0 · Other (J): 88,000 (derivative) @ $0EDGAR
2023-02-164Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Conversion (C): 4,314,093 · Purchase (P): 250,000 @ $16 · Conversion (C): 2,171,342 (derivative) @ $0 · Conversion (C): 2,142,751 (derivative) @ $0EDGAR
2023-02-134Mineralys Therapeutics, Inc. (MLYS)
jointly with Catalys Pacific Fund, LP
Grant/award (A): 44,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1963901 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs